Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10015788HBVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS10030970HBVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30016566HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30004041HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30004042HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30009434HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30017290HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068168HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068169HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068170HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TCGA Plot Options
Drug Information
GeneBRAF
DrugBank IDDB11718
Drug NameEncorafenib
Target IDBE0000634
UniProt IDP15056
Regulation Typeinhibitor
PubMed IDs26586345; 29356698; 25769717
CitationsLi Z, Jiang K, Zhu X, Lin G, Song F, Zhao Y, Piao Y, Liu J, Cheng W, Bi X, Gong P, Song Z, Meng S: Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells. Cancer Lett. 2016 Jan 28;370(2):332-44. doi: 10.1016/j.canlet.2015.11.015. Epub 2015 Nov 14.@@Koelblinger P, Thuerigen O, Dummer R: Development of encorafenib for BRAF-mutated advanced melanoma. Curr Opin Oncol. 2018 Mar;30(2):125-133. doi: 10.1097/CCO.0000000000000426.@@Moschos SJ, Pinnamaneni R: Targeted therapies in melanoma. Surg Oncol Clin N Am. 2015 Apr;24(2):347-58. doi: 10.1016/j.soc.2014.12.011. Epub 2015 Jan 24.
GroupsApproved; Investigational
Direct ClassificationPhenylpyrazoles
SMILESCOC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C
Pathways
PharmGKBPA166179872
ChEMBLCHEMBL3301612